These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
974 related articles for article (PubMed ID: 21921786)
1. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas. Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786 [TBL] [Abstract][Full Text] [Related]
2. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Wang WL; Soslow R; Hensley M; Asad H; Zannoni GF; de Nictolis M; Branton P; Muzikansky A; Oliva E Am J Surg Pathol; 2011 Apr; 35(4):522-9. PubMed ID: 21383611 [TBL] [Abstract][Full Text] [Related]
3. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594 [TBL] [Abstract][Full Text] [Related]
5. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039 [TBL] [Abstract][Full Text] [Related]
7. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. D'Angelo E; Spagnoli LG; Prat J Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555 [TBL] [Abstract][Full Text] [Related]
8. Use of myocardin in the classification of mesenchymal tumors of the uterus. Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936 [TBL] [Abstract][Full Text] [Related]
9. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms. Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354 [TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis. Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932 [TBL] [Abstract][Full Text] [Related]
11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
12. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma". Kraft S; Fletcher CD Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302 [TBL] [Abstract][Full Text] [Related]
16. Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma. Al-Daraji WI; Makhlouf HR; Miettinen M; Montgomery EA; Goodman ZD; Marwaha JS; Fanburg-Smith JC Am J Surg Pathol; 2009 Jun; 33(6):826-34. PubMed ID: 19194282 [TBL] [Abstract][Full Text] [Related]
17. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127 [TBL] [Abstract][Full Text] [Related]
18. Primary and secondary leiomyosarcoma of the oral and perioral region--clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature. Schütz A; Smeets R; Driemel O; Hakim SG; Kosmehl H; Hanken H; Kolk A J Oral Maxillofac Surg; 2013 Jun; 71(6):1132-42. PubMed ID: 23434173 [TBL] [Abstract][Full Text] [Related]
19. The selected biomarker analysis in 5 types of uterine smooth muscle tumors. Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902 [TBL] [Abstract][Full Text] [Related]
20. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study. Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]